The risk of primary peritoneal carcinoma is also increased in patients carrying BRCA1 (and BRCA2) mutations with a cumulative lifetime risk of between 1.3–20% [6,9,10]. The gene discussed is BRCA1; the disease is peritoneal carcinoma.